BioMed Research International

Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets


Status
Published

Lead Editor

1ICB-UFMG, Belo Horizonte, Brazil

2University of Freiburg Medical School, Freiburg im Breisgau, Germany

3UCSF, San Francisco, USA

4University of Florida, Gainesville, USA

5Asklepios-Med, Szeged, Hungary


Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets

Description

Neuroinflammatory and neurodegenerative disorders affect millions of people worldwide, but the pathophysiological aspects of most of them remain poorly understood. Several molecules have been suggested as participants in the process of these diseases and might represent pharmacological targets.

We invite researchers to submit reviews and original articles that explore the most recent discoveries in the pathological mechanisms of neuroinflammatory and neurodegenerative diseases and potential upcoming therapies.

Potential topics include, but are not limited to:

  • Role of the peripheral immune system in neurodegeneration
  • Role of inflammatory mediators in neurodegeneration
  • Potential targets that control neuroinflammation and degeneration
  • Drugs that reveal neuroprotective and antineuroinflammatory properties
  • From basic to clinical science in neuroimmunopharmacology
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit